4//SEC Filing
Moses Jennifer K. 4
Accession 0001562180-22-000956
CIK 0001560241other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:20 PM ET
Size
14.5 KB
Accession
0001562180-22-000956
Insider Transaction Report
Form 4
Moses Jennifer K.
VP of Finance & Admin
Transactions
- Exercise/Conversion
Common Stock
2022-02-01$4.17/sh+2,000$8,340→ 37,888 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-01−2,000→ 58,000 totalExercise: $4.17Exp: 2026-05-10→ Common Stock (2,000 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2022-02-01−333→ 0 totalExercise: $3.72Exp: 2025-12-21→ Common Stock (333 underlying) - Exercise/Conversion
Common Stock
2022-02-01$3.72/sh+333$1,239→ 35,888 total
Footnotes (3)
- [F1]Represents (i) 15,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
- [F2]Represents (i) 17,638 shares of common stock; (ii) 8,250 RSUs from award granted on January 4, 2021; and (iii) 12,000 RSUs from award granted on January 3, 2022.
- [F3]All shares underlying this option have vested.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001706667
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:20 PM ET
- Size
- 14.5 KB